Biohit Oyj Statistics

Total Valuation

Biohit Oyj has a market cap or net worth of EUR 46.61 million. The enterprise value is 40.51 million.

Market Cap	46.61M
Enterprise Value	40.51M

Important Dates

The last earnings date was Wednesday, February 12, 2025.

Earnings Date	Feb 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Biohit Oyj has 15.18 million shares outstanding. The number of shares has increased by 1.10% in one year.

Current Share Class	n/a
Shares Outstanding	15.18M
Shares Change (YoY)	+1.10%
Shares Change (QoQ)	+1.97%
Owned by Insiders (%)	19.41%
Owned by Institutions (%)	n/a
Float	7.11M

Valuation Ratios

The trailing PE ratio is 18.06 and the forward PE ratio is 20.47.

PE Ratio	18.06
Forward PE	20.47
PS Ratio	3.25
PB Ratio	3.82
P/TBV Ratio	3.98
P/FCF Ratio	233.04
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.97, with an EV/FCF ratio of 202.54.

EV / Earnings	15.58
EV / Sales	2.83
EV / EBITDA	13.97
EV / EBIT	15.58
EV / FCF	202.54

Financial Position

The company has a current ratio of 3.67, with a Debt / Equity ratio of 0.05.

Current Ratio	3.67
Quick Ratio	3.30
Debt / Equity	0.05
Debt / EBITDA	0.21
Debt / FCF	3.00
Interest Coverage	8.67

Financial Efficiency

Return on equity (ROE) is 24.05% and return on invested capital (ROIC) is 14.17%.

Return on Equity (ROE)	24.05%
Return on Assets (ROA)	11.44%
Return on Invested Capital (ROIC)	14.17%
Return on Capital Employed (ROCE)	20.80%
Revenue Per Employee	310,870
Profits Per Employee	56,522
Employee Count	46
Asset Turnover	1.01
Inventory Turnover	5.29

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +59.07% in the last 52 weeks. The beta is 0.89, so Biohit Oyj's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	+59.07%
50-Day Moving Average	2.84
200-Day Moving Average	2.35
Relative Strength Index (RSI)	52.70
Average Volume (20 Days)	17,077

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biohit Oyj had revenue of EUR 14.30 million and earned 2.60 million in profits. Earnings per share was 0.17.

Revenue	14.30M
Gross Profit	9.30M
Operating Income	2.60M
Pretax Income	2.90M
Net Income	2.60M
EBITDA	2.90M
EBIT	2.60M
Earnings Per Share (EPS)	0.17

Full Income Statement

Balance Sheet

The company has 6.70 million in cash and 600,000 in debt, giving a net cash position of 6.10 million or 0.40 per share.

Cash & Cash Equivalents	6.70M
Total Debt	600,000
Net Cash	6.10M
Net Cash Per Share	0.40
Equity (Book Value)	12.20M
Book Value Per Share	0.80
Working Capital	8.00M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 600,000 and capital expenditures -400,000, giving a free cash flow of 200,000.

Operating Cash Flow	600,000
Capital Expenditures	-400,000
Free Cash Flow	200,000
FCF Per Share	0.01

Full Cash Flow Statement

Margins

Gross margin is 65.03%, with operating and profit margins of 18.18% and 18.18%.

Gross Margin	65.03%
Operating Margin	18.18%
Pretax Margin	20.28%
Profit Margin	18.18%
EBITDA Margin	20.28%
EBIT Margin	18.18%
FCF Margin	1.40%

Dividends & Yields

Biohit Oyj does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.10%
Shareholder Yield	-1.10%
Earnings Yield	5.58%
FCF Yield	0.43%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Biohit Oyj has an Altman Z-Score of 8.49.

Altman Z-Score	8.49
Piotroski F-Score	n/a